English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/41526
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

3- Oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments

AuthorsMoreno, Beatriz; Villoslada, Pablo; Messeguer, Joaquim; Navarro, Gloria; Messeguer Peypoch, Ángel
Issue Date3-Mar-2011
CitationWO2011024078 A1
AbstractNew 3-oxopiperazinium derivatives agonists ofNerve Growth Factor receptors and their use as medicaments. Neurotrophin binding to its specific receptor Trk A leads to the activation of multiple signalling cascades, culminating in neuroregenerative effects, incIuding neuronal survival and neurite outgrowth. Neurotrophic factors have been used for the treatment of several neurodegenerative diseases. However, their use is limited by their inability to cross the blood-brain barrier, their short half life and their side effects. Small molecule neurotrophin peptidomimetics may be beneficial in treating a number of neurodegenerative disorders. The present invention shows the capacity of nerve growth factor agonist molecules derived from the 3- oxopiperazinium scaffold to induce differentiation in PC12 cells and, therefore, that these small molecules with NGF agonist activity may be beneficial for treatment of neurodegenerative diseases, due to their neuroregenerative effects.
Appears in Collections:(IQAC) Patentes
Files in This Item:
File Description SizeFormat 
WO2011024078A1.pdf3,03 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.